Zydus receives final approval from USFDA for Eluxadoline Tablets, 75 mg and 100 mg
Eluxadoline is a mu-opioid receptor agonist, indicated in adults for the treatment of irritable bowel syndrome with diarrhoea
Eluxadoline is a mu-opioid receptor agonist, indicated in adults for the treatment of irritable bowel syndrome with diarrhoea
Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
Methenamine Hippurate tablets are indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections
Amplitude Surgical is a European MedTech leader in high-quality, lower-limb orthopaedic technologies
Havix was incorporated under the laws of the State of Delaware on February 17, 2015
Overall investment in the US facility is estimated around US$50 million
Ketoconazole shampoo is an antifungal medication used to treat dandruff
Biotech potential of Himalayan territories including Jammu & Kashmir, particularly their agri-biotech potential remains still under-explored
ANVIMO will be available in dosages of 240 mg and 480 mg
The company will provide the necessary response on these observations to USFDA within stipulated 15 days
Subscribe To Our Newsletter & Stay Updated